hVIVO plc Exercise of Share Options (0431B)
18 September 2018 - 4:01PM
UK Regulatory
TIDMHVO
RNS Number : 0431B
hVIVO plc
18 September 2018
HVIVO PLC
("hVIVO" or the "Company")
Exercise of Share Options
London, UK, 18 September 2018: hVIVO plc (AIM: HVO), a pioneer
of human disease models and an industry leading clinical
development services business, announces that, following the
exercise of employee share options, application has been made to
AIM for the admission of 1,366,320 new ordinary shares of 5.0p each
(the "New Ordinary Shares").
Admission to trading on AIM of the New Ordinary Shares
("Admission"), which will rank pari passu in all respects with the
Company's existing shares in issue, is expected to occur on 21
September 2018.
Following Admission, the total number of ordinary shares with
voting rights in issue will be 80,575,074 and this figure may be
used by shareholders as the denominator for the calculations by
which they will determine if they are required to notify their
interest in, or a change to their interest in, the Company under
the Financial Conduct Authority's Disclosure and Transparency
Rules.
For further information please contact:
hVIVO plc
Trevor Phillips (Executive Chairman) +44 207 756 1300
Fleur Wood (EVP, IR & Comms)
Numis Securities Limited +44 207 260 1000
Michael Meade / Freddie Barnfield
(Nominated Adviser)
James Black / Michael Burke (Corporate
Broking)
FTI Consulting
Simon Conway / Victoria Foster Mitchell +44 203 727 1000
Notes to Editors:
hVIVO plc ("hVIVO") is pioneering a human-based analytical
platform to accelerate drug discovery and development in
respiratory and infectious diseases. Leveraging human disease
models in flu, RSV and asthma exacerbation, the hVIVO platform
captures disease in motion, illuminating the entire disease life
cycle from healthy to sick and back to health. Based in the UK,
market leader hVIVO has conducted more than 50 clinical studies,
inoculated over 2500 volunteers and has three first-in-class
therapies currently in development.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
IOELFFIIARIDLIT
(END) Dow Jones Newswires
September 18, 2018 02:01 ET (06:01 GMT)
Hvivo (LSE:HVO)
Historical Stock Chart
From Apr 2024 to May 2024
Hvivo (LSE:HVO)
Historical Stock Chart
From May 2023 to May 2024